Image

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

Recruiting
18 - 65 years of age
Both
Phase 1/2

Powered by AI

Overview

The objectives of this study are to test the preliminary safety and efficacy of a two-day peri-operative course of treprostinil in reducing ischemia-reperfusion injury in adult patients receiving a deceased donor kidney transplantation. Treprostinil, a prostacyclin analog, is expected to facilitate the restoration of blood supply to the revascularized kidney graft via its vasodilatory actions, well characterized protective effects, and longer elimination half-life. These properties and actions of treprostinil make it a strong drug candidate to reduce kidney graft dysfunction during kidney transplantation. An anticipated 20 participants undergoing deceased donor kidney transplant will be hospitalized and intensively monitored during an entire two-day Treatment Phase. An IV infusion using a dedicated central venous line will be used to administer treprostinil commencing approximately 2-3 hours before transplantation of the kidney graft and will continue for approximately 48 hours after completion of the transplant surgery. The primary endpoints include the safety and efficacy of treprostinil, with secondary endpoints including the evaluation of both biochemical and clinical endpoints post-transplantation.

Eligibility

Inclusion Criteria:

  1. Male and female patients who will receive a deceased donor kidney aged 18 to 65 (inclusive) and are currently on the active transplant list at RIH.
  2. Documentation of a diabetes diagnosis as evidenced by one or more clinical features consistent will be noted for all patients.
  3. Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.

Exclusion Criteria:

  1. Under the age of 18 years
  2. Difficult venous access
  3. BMI > 40 kg/m2
  4. Patients with severe clinical gastroparesis as determined by repeated vomiting
  5. Prior GI surgery except for cholecystectomy, appendectomy, or Nissen fundoplication
  6. Known or history of inflammatory bowel disease or bezoars
  7. History of diverticulitis, diverticular stricture, and other intestinal strictures
  8. Be receiving any investigational drug other than treprostinil or participating in any other investigational study
  9. Be receiving any prostanoid therapy to treat portopulmonary hypertension
  10. Have any known hypersensitivity to prostaglandins, prostacyclin or treprostinil
  11. Have had a failed kidney transplant within the previous 180 days
  12. Be receiving any non-standard immunosuppression protocol or other non-standard treatment that could affect interpretation of the study results
  13. Those with significant cardiovascular disease including treatment with inotropes
  14. If female, be pregnant or nursing (confirmed by urine test)
  15. Presence of a condition or abnormality that in the opinion of the Investigators that would compromise the safety of the patient or the quality of the data

Study details

Ischemia Reperfusion Injury, Delayed Graft Function

NCT04005469

Rhode Island Hospital

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.